Determination of human papillomavirus type in archival tissue specimens of invasive cervical cancer using molecular mapping and E6/E7-based polymerase chain reaction

PLoS One. 2022 Apr 5;17(4):e0265996. doi: 10.1371/journal.pone.0265996. eCollection 2022.

Abstract

In our previous study, an L1-based human papillomavirus (HPV) test using liquid-based cytology revealed that some invasive cervical cancers (ICC) exhibited multiple HPV types or harbored no HPV DNA. Here, molecular mapping of formalin-fixed paraffin-embedded cancer tissue specimens from the same patients were conducted to confirm these observations. Among 377 ICC cases, 73 eligible specimens (9 positive for multiple HPV types, 16 negative for HPV, and 48 positive for a single HPV type from the previous study) were reexamined by manual microdissection of cancer lesions, then subjected to HPV genotyping using the uniplex E6/E7 polymerase-chain-reaction method to detect all high-risk and potentially high-risk HPV types. The HPV typing results were confirmed in 52 of 73 cancer cases; among the 21 remaining cases, 15 were discordant and 6 were partially concordant. In total, 8 of 16 (50%) HPV-negative samples became positive; 6 were positive for HPV16 and 2 were positive for HPV67. Moreover, two samples previously positive for HPV6 and HPV53 were negative for HPV. All nine cancers with multiple HPV types were found to harbor only a single HPV type. In total, 63 cancer tissues exhibited a single HPV type. HPV16 and HPV18 were detected in squamous cell carcinoma (SCC) and adenocarcinoma (ADC). Alpha-5 (HPV82), -6 (HPV56), and -9 (HPV31/52/67) HPV types were detected in SCC, whereas Alpha-7 (HPV59/68) types were detected in ADC and adenosquamous carcinoma (ADSCC). These findings suggested that the different HPV types induced different histological cancers. Furthermore, all SCCs and 10 of 11 usual-type ADCs were positive for high-risk HPV types, supporting the use of HPV screening for the detection of these cancers and associated premalignant lesions. HPV16 is likely to remain undetected in some cervical cancer tissues because of low viral-copy-numbers. Putative high-risk HPV types (e.g., HPV67 and HPV82) might be high risk in Japan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma*
  • Alphapapillomavirus* / genetics
  • Carcinoma, Squamous Cell*
  • DNA, Viral / analysis
  • DNA, Viral / genetics
  • Female
  • Human papillomavirus 16 / genetics
  • Humans
  • Oncogene Proteins, Viral* / genetics
  • Papillomaviridae / genetics
  • Papillomavirus Infections*
  • Polymerase Chain Reaction
  • Uterine Cervical Neoplasms* / diagnosis

Substances

  • DNA, Viral
  • Oncogene Proteins, Viral

Grants and funding

This work was supported by JSPS KAKENHI [Grant Number JP19K18712; Recipient: Jinichi Sakamoto]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder Website: https://www.jsps.go.jp/index.html.